Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Published:2020-07-13 Issue:7 Volume:49 Page:897-903
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Sell Naomi M.,Lee Grace C.,Fernández-Del Castillo Carlos,Ferrone Cristina R.,Warshaw Andrew L.,Hong Theodore S.,Blaszkowsky Lawrence S.,Lillemoe Keith D.,Qadan Motaz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Cancer statistics, 2019;CA Cancer J Clin,2019

2. Recent progress in pancreatic cancer;CA Cancer J Clin,2013

3. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival;Ann Surg Oncol,2006

4. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer;Ann Surg,2015

5. Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment with FOLFIRINOX;Ann Surg,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma;HPB;2024-09

2. Disparities in neoadjuvant chemotherapy for pancreatic adenocarcinoma with vascular involvement;Surgery Open Science;2024-08

3. Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence;Surgery;2024-08

4. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy;JAMA Network Open;2024-06-18

5. Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma;Journal of Gastrointestinal Surgery;2024-05